References
- Clark M. Gosnell M, Hager M, et al. The calcium craze. Newsweek 1986 Jan 27: 48–52
- Seeman E, Riggs BL. Dietary prevention of bone loss in the elderly. Geriatrics 1981: 36(9): 71–3, 75, 79
- Phillips S, Fox N, Jacobs J, et al. The direct medical costs of osteoporosis for American women aged 45 and older, 1986. Bone 1988: 9(5): 271–9
- Albanesc AA. Calcium nutrition in the elderly: maintaining bone health to minimize fracture risk. Postgrad Med 1978: 63(3): 167–72
- Riggs BL, Wahner HW, Dunn WL, et al. Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Can Invest 1981: 67(2): 328–35
- Heaney RP, Recher RR, Saville PD. Menopausal changes in calcium balance performance. J Lab Clin Med 1978: 92(6): 953–63
- Heath H 3d. Progress against osteoporosis. Ann Intern Med 1983: 98(6): 1011–3
- Koetting CA, Wardlaw GM. Wrist, spine, and hip bone density in women with variable histories of lactation. Am J Clin Nutr 1988: 48(6): 1479–81
- Heaney RP. The role of nutrition in prevention and management of osteoporosis. Clin Obstet Gynecol 1987: 30(4): 833–46
- Roberts HJ. Potential toxicity due to dolomite and bonemeal. South Med J 1983: 76(5): 556–9
- Burros M. Calcium tablets are not all created equal. NY Times 1988 Jan 27: C1, 8
- Jensen GF, Christiansen C, Transbol IB. Fracture frequency and bone preservation in postmenopausal women treated with estrogen. Obstet Gynecol 1982: 60(4): 493–6
- Aloia JF. Estrogen and exercise in prevention and treatment of osteoporosis. Geriatrics 1982: 37(6): 81–5
- Hillner BE, Hollenberg JP, Pauker SG. Postmenopausal estrogens in prevention of osteoporosis: benefit virtually without risk if cardiovascular effects are considered. Am J Med 1986: 80(6): 1115–27
- Riggs BL, Seeman E, Hodgson SF, et al. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis: comparison with conventional therapy. N Engl J Med 1982: 306(8): 446–50
- Horsman A, Jones M, Francis R, et al. The effect of estrogen dose on postmenopausal bone loss. N Engl J Med 1983: 309(23): 1405–7
- Selby PL, Peacock M. The effect of transdermal oestrogen on bone, calcium-regulating hormones and liver in postmenopausal women. Clin Endocrinol (Oxf) 1986: 25(5): 543–7
- Chesnut CH 3d, Nelp WB, Baylink DJ, et al. Effect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total Done mineral mass. Metabolism 1977: 26(3): 267–77
- Aloia JF, Kapoor A, Vaswani A, et al. Changes in body composition following therapy of osteoporosis with methandrostenolone. Metabolism 1981: 30(11): 1076–9
- Wasnich RD, Benfante RJ, Yano K, et al. Thiazide effect on the mineral content of bone. N Engl J Med 1983: 309(6): 344–7
- Schapira D. Physical exercise in the prevention and treatment of osteoporosis: a review. J R Soc Med 1988: 81(8): 461–3